Do we need B7-H3 immunohistochemistry for the inclusion of children with high-grade central nervous system tumors in clinical trials targeting B7-H3?Mariëtte E.G. Kranendonk, Sabine Plasschaert, Julie A S Lammers et al.|Neuro-Oncology|2025Cited by 6